ALVIO — Valerio Therapeutics SA Balance Sheet
0.000.00%
- €9.39m
- €16.91m
- €1.79m
Annual balance sheet for Valerio Therapeutics SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 14.5 | 17.9 | 14.6 | 6.82 | 1.18 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 8.25 | 10.8 | 5.71 | 5.01 | 3.27 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 23.2 | 30.1 | 20.6 | 13 | 4.57 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.56 | 2.24 | 1.89 | 1.53 | 1.17 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 46.5 | 53.1 | 43.1 | 35.3 | 17.9 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6.05 | 7.06 | 7.15 | 11.1 | 18.3 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 17.5 | 20.1 | 20.8 | 20.5 | 26.9 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 29 | 32.9 | 22.3 | 14.8 | -8.93 |
| Total Liabilities & Shareholders' Equity | 46.5 | 53.1 | 43.1 | 35.3 | 17.9 |
| Total Common Shares Outstanding |